✨ Free AI Report
Aarti Drugs Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Aarti Drugs Limited
Research Preview

Aarti Drugs Limited: Business Overview, Financials & Competitive Analysis

Aarti Drugs Limited is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals, established in 1984. The company operates as part of the $900 mi...

Analyst-debate audio for Aarti Drugs Limited

AskCyborg analysts argue the bull and bear cases for Aarti Drugs Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Aarti Drugs Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Strong API portfolio and global export presence positioned favorably as Indian manufacturers gain share amid China supply...

Read the full analyst-debate transcript →
Industry Pharmaceutical Active Ingredients (APIs) & Specialty Chemicals
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Aarti Drugs Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Aarti Drugs Limited Overview

Pro stress-test →

Aarti Drugs Limited is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals, established in 1984. The company operates as part of the $900 million Aarti Group and exports to over 100 countries, serving critical therapeutic markets including antibiotics, anti-diabetics, and anti-inflammatories.

Strategic Profile

Pro stress-test →

Aarti Drugs holds market leadership in 50+ API molecules and is the world's largest manufacturer of key products like Fluoroquinolones, Tinidazole, and Metronidazole Benzoate. The company operates with GMP-certified manufacturing units and pursues vertical integration through its wholly-owned subsidiary Pinnacle Life Science, which focuses on formulation development to capture higher margins in the pharmaceutical value chain.

Competitive Landscape

Pro stress-test →

Aarti Drugs competes in the fragmented Indian API market against peers like Divi's Laboratories, Laurus Labs, and Neuland Pharma. Indian API manufacturers are gaining global market share as customers diversify away from China-dependent supply chains. Divi's Labs achieved 19.3% revenue growth in FY25, while Laurus and Neuland posted strong profitability growth, creating competitive pressure despite Aarti's established market position in specific molecules.

Industry Context

Aarti Drugs Limited operates in Pharmaceutical Active Ingredients (APIs) & Specialty Chemicals.

Key facts

Founded: 1984 · Headquarters: Mumbai, India · Revenue: ₹2,403 Cr (~$287M) FY2025-26 · Market cap: ₹3,358-3,511 Cr (~$400-420M)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Aarti Drugs Limited.

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Aarti Drugs Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

API ManufacturingGlobal leader in generic APIs with 19.3% FY25 revenue growth→API ManufacturingStrong Q2 FY26 performance with robust profit growth→API ManufacturingEmerging competitor with strong profitability momentum→

Compare Aarti Drugs Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Aarti Drugs Limited operates in Pharmaceutical Active Ingredients (APIs) & Specialty Chemicals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Active Ingredients (APIs) & Specialty Chemicals research →
NEW · MCP server

Ask your AI assistant about Aarti Drugs Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Aarti Drugs Limited and its top competitor on Cyborg Score”
“What did Aarti Drugs Limited do this quarter?”
“Is Aarti Drugs Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Aarti Drugs Limited do?+
Aarti Drugs Limited is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals, established in 1984. The company operates as part of the $900 mi...
What is Aarti Drugs Limited's Cyborg Score?+
Aarti Drugs Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Aarti Drugs Limited's main competitors?+
Named competitors include API Manufacturing, API Manufacturing, API Manufacturing. The full competitive landscape is in the AskCyborg report.
How can I get the full Aarti Drugs Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Aarti Drugs Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Aarti Drugs Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.